Skip to main content
logo
Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7090
+0.0169 (2.44%)
At close: Sep 29, 2026, 4:00 PM EDT
0.6812
-0.0278 (-3.92%)
After-hours: Sep 29, 2026, 4:50 PM EDT

Envoy Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Market Capitalization
5561511918302829644677351371,425---
Market Cap Growth (YoY)
194.93%101.06%84.43%-34.26%-71.01%-34.53%-63.82%-18.21%-53.55%-96.75%-------
Enterprise Value
3637481642494240714770292141,490---
Last Close Price
0.710.790.670.660.781.421.301.433.252.363.921.817.0110.2410.0510.029.74

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
PS Ratio
264.40294.15218.5278.9788.80136.41130.78128.67229.14153.17258.03112.02569.066536.43---
PB Ratio
14.8216.484.85-1.62-2.45-1.01-1.14-1.54-3.44-3.73-10.34-19.9328.66-23.87---
P/TBV Ratio
14.8216.484.85---------28.66----

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
EV/Sales Ratio
173.25176.46206.4768.14202.00220.72197.65178.38253.75154.53234.9790.34886.576833.68---

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Debt / Equity Ratio
0.220.220.08-0.08-0.13-0.97-0.99-1.04-0.84-0.69-0.72-0.320.12-0.95-0.97-0.95-0.94
Net Debt / Equity Ratio
-5.11-5.11-2.310.240.35-0.79-0.77-0.75-0.60-0.55-0.052.06-1.43-0.95-0.94-0.95-0.89
Net Debt / EBITDA Ratio
0.820.821.080.130.13-1.21-0.97-0.74-0.53-0.35-0.020.200.48-4.40-4.24-3.98-3.29
Net Debt / FCF Ratio
0.870.871.180.150.15-1.47-1.10-0.75-0.44-0.32-0.020.210.81-4.68-4.44-3.81-3.17
Asset Turnover
0.010.010.010.020.020.030.020.020.020.070.050.06---0.09-
Inventory Turnover
0.520.520.490.420.500.510.520.480.540.590.560.59---0.42-
Quick Ratio
1.561.562.070.330.400.670.710.840.510.240.740.610.670.030.340.090.87
Current Ratio
1.741.742.270.540.640.941.091.180.790.621.111.021.600.410.760.651.76
Return on Assets (ROA)
-86.53%-86.53%-71.29%-137.34%-145.31%-148.00%-129.07%-121.51%-87.51%-265.85%-202.46%-211.96%----210.09%-
Return on Capital Employed (ROCE)
-207.10%-207.10%-130.20%735.00%2532.10%-1036.70%-698.20%-481.40%-6634.70%1502.10%-1312.10%-1862.00%-170.60%812.60%-10159.00%-23529.70%-554.10%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Earnings Yield
-51.99%-38.43%-45.19%-124.83%-117.97%-70.22%-70.42%-71.83%-33.08%-29.49%-29.93%-84.53%-26.62%-2.76%---
FCF Yield
-39.67%-35.66%-40.50%-96.58%-92.48%-52.79%-61.18%-65.39%-40.09%-45.97%-25.93%-48.72%-6.20%-0.85%---
Buyback Yield / Dilution
-177.04%-177.04%-80.58%-23.78%-12.58%-21.98%-35.09%-52.83%-83.66%88.12%89.64%-21.46%-0.19%----
SEC Filings: 10-K · 10-Q